ASRS 2019 Street Team: Raj K. Maturi, MD


ICYMI: Abicipar Phase II MAPLE Trial supports improved safety for patients with nAMD following a Modified Manufacturing Process

Raj K. Maturi, MD, discusses phase II data from the abicipar Phase II MAPLE Trial for patients with AMD at the 2019 annual ASRS conference.

Related Videos
© 2023 MJH Life Sciences

All rights reserved.